Citations

Clear

1792 citation(s) found for "Stephanie".

Brain atrophy in picornavirus‐infected FVB mice is dependent on the H‐2D b class I molecule
Kelcher, April M. Huseby , Atanga, Pascal Aliihnui, Gamez, Jeffrey D., Garcia, Luz Milbeth Cumba, Teclaw, Stephanie J., Johnson, Aaron J. , Huseby Kelcher, April M, Atanga, Pascal A, Cumba Garcia, Luz M, Pavelko, Kevin D. , Macura, Slobodan I, Macura, Slobodan , Johnson, Aaron J. , Kelcher, April M H

Mayo Clinic

The FASEB Journal | February 14, 2017 | Volume: 31 | Issue: 6 | Pages: 2267-2275

10.1096/fj.201601055r | PMID 28188174 Get It

ABSTRACT Brain atrophy is a common feature of numerous neurologic diseases in which the role of neuroinflammation remains ill‐defined. In this study, we evaluated the contribution of major histocompatibility complex class I molecules to brain atrophy in Theiler's murine encephalomyelitis virus (TMEV)–infected transgenic FVB mice that express the D b class I molecule. FVB/D b and wild‐type FVB mice were evaluated for changes in neuroinflammation, virus clearance, neuropathology, and development of brain atrophy via T2‐weighted MRI and subsequent 3‐dimensional volumetric analysis. Significant brain atrophy and hippocampal neuronal loss were observed in TMEV‐infected FVB/D b mice, but not in wild‐type FVB mice. Brain atrophy was observed at 1 mo postinfection and persisted through the 4‐mo observation period. Of importance, virus‐infected FVB/D b mice elicited a strong CD8 T‐cell response toward the immunodominant D b ‐restricted TMEV‐derived peptide, VP2 121–130 , and cleared TMEV from the CNS. In addition, immunofluorescence revealed CD8 T cells near virus‐infected neurons; therefore, we hypothesize that class I restricted CD8 T‐cell responses promote development of brain atrophy. This model provides an opportunity to analyze the contribution of immune cells to brain atrophy in a system where persistent virus infection and demyelination are not factors in long‐term neuropathology.—Huseby Kelcher, A. M., Atanga, P. A., Gamez, J. D., Cumba Garcia, L. M., Teclaw, S. J., Pavelko, K. D., Macura, S. I., Johnson, A. J. Brain atrophy in picornavirus‐infected FVB mice is dependent on the H‐2Db class I molecule. FASEB J. 31, 2267–2275 (2017). www.fasebj.org
Tube Thoracostomy Complications Increase Cost
Zeb, Muhammad, Heller, Stephanie F. , Zielinski, Martin D. , Aho, Johnathon M. , Hernandez, Matthew C. , Zeb, Muhammad H

Mayo Clinic

World Journal of Surgery | January 24, 2017 | Volume: 41 | Issue: 6 | Pages: 1482-1487

10.1007/s00268-017-3897-7 | PMID 28120094 Get It

Abstract Background Tube thoracostomy (TT) can be an effective therapy for thoracic pathologies. Ineffective placement of TT is common and associated with significant complications. Complications require additional interventions to repair damaged tissues or replace dysfunctional TT. We hypothesize that complicated TT insertion increases cost to the hospital system. Methods Adult trauma patients requiring TT at a level 1 trauma center (2012–2013) were reviewed. Intraoperative or image‐guided TT placements were excluded. Baseline demographics and TT insertion cost (normalized and assigned by hospital billing records) were recorded. Costs included initial TT equipment, radiographs, and subsequent operative or radiologic intervention to correct TT complications. Complications were categorized using previously validated method. Secondary outcomes included: number of TT inserted, number of chest radiographs performed, and TT dwell time utilizing a standardized TT discontinuation protocol. Results A total of 154 patients with 246 TT were included. Ninety TT (37%) had complication. Complication categories are postremoval ( n = 15, 16.7%), insertional ( n = 13, 14.4%), positional ( n = 62, 68.9%). Overall median complicated TT cost was 9 times greater than uncomplicated TT insertion, p = 0.001. Insertional complications median cost 21 times greater than an uncomplicated, due to operative and radiologic interventions ( p = 0.0001). Positional and postremoval complication rates increased median cost by 3 times compared to uncomplicated TT ( p = 0.03). Operative or radiologic interventions ( n = 10) were performed for organ injury or uncontrolled hemo‐/pneumothorax. Increased dwell time median [IQR] was associated with complicated TT compared to uncomplicated 3 [1–5] versus 2 [1–3], p = 0.01. Conclusion TT is a common procedure. TT complications are often considered benign. However, patients with a complicated TT insertion, especially related to insertional subtypes, have markedly increased hospitalization costs due to need for operative or radiologic repair. Level of evidence Level V—retrospective study. Study type This is a retrospective single‐institution study.
Impact of pre‐transplant depression on outcomes of allogeneic and autologous hematopoietic stem cell transplantation
El‐Jawahri, Areej , Chen, Yi‐Bin, Brazauskas, Ruta , He, Naya, Lee, Stephanie J. , Knight, Jennifer M. , Majhail, Navneet S. , Buchbinder, David , Schears, Raquel M. , Wirk, Baldeep , Wood, William A. , Ahmed, Ibrahim , Aljurf, Mahmoud , Beattie, Sara , Dandoy, Christopher E. , Díaz, Miguel Ángel , D’Souza, Anita , Freytes, César O. , Gajewski, James , Hashmi, Shahrukh K. , Jakubowski, Ann A. , Kamble, Rammurti T., Kindwall‐Keller, Tamila L. , Lazarus, Hilard M., Malone, Adriana K. , Marks, David I. , Meehan, Kenneth R., Olsson, Richard F. , Rizzieri, David A. , Steinberg, Amir , Speckhart, Dawn, Szwajcer, David , Schoemans, Hélène , Seo, Sachiko , Üstün, Celalettin , Dalal, Jignesh , Sales‐Bonfim, Carmem, Khera, Nandita , Hahn, Theresa , Saber, Wael , Chen, Yi‐Bin , Szer, Jeff , Battiwalla, Minoo , Gergis, Usama , Savani, Bipin N. , Atsuta, Yoshiko , D'Souza, Anita , Olsson, Richard F , Majhail, Navneet S , Knight, Jennifer M , Diaz Perez, Miguel Angel , Dandoy, Christopher E , Lee, Stephanie J , Wood, William A

Mayo Clinic

Cancer | January 19, 2017 | Volume: 123 | Issue: 10 | Pages: 1828-1838

10.1002/cncr.30546 | PMID 28102896 Get It

BACKGROUNDTo evaluate the impact of depression before autologous and allogeneic hematopoietic cell transplantation (HCT) on clinical outcomes post‐transplantation.METHODSWe analyzed data from the Center for International Blood and Marrow Transplant Research to compare outcomes after autologous (n = 3786) or allogeneic (n = 7433) HCT for adult patients with hematologic malignancies with an existing diagnosis of pre‐HCT depression requiring treatment versus those without pre‐HCT depression. Using Cox regression models, we compared overall survival (OS) between patients with or without depression. We compared the number of days alive and out of the hospital in the first 100 days post‐HCT using Poisson models. We also compared the incidence of grade 2‐4 acute and chronic graft‐versus‐host disease (GVHD) in allogeneic HCT.RESULTSThe study included 1116 (15%) patients with pre‐transplant depression and 6317 (85%) without depression who underwent allogeneic HCT between 2008 and 2012. Pre‐transplant depression was associated with lower OS (hazard ratio [HR], 1.13; 95% confidence interval [CI], 1.04‐1.23; P = 0.004) and a higher incidence of grade 2‐4 acute GVHD (HR, 1.25; 95% CI, 1.14‐1.37; P < 0.0001), but similar incidence of chronic GVHD. Pre‐transplant depression was associated with fewer days‐alive‐and‐out‐of‐the hospital (means ratio [MR] = 0.97; 95% CI, 0.95‐0.99; P = 0.004). There were 512 (13.5%) patients with Pre‐transplant depression and 3274 (86.5%) without depression who underwent autologous HCT. Pre‐transplant depression in autologous HCT was not associated with OS (HR, 1.15; 95% CI, 0.98‐1.34; P = 0.096) but was associated with fewer days alive and out of the hospital (MR, 0.98; 95% CI, 0.97‐0.99; P = 0.002).CONCLUSIONPre‐transplant depression was associated with lower OS and higher risk of acute GVHD among allogeneic HCT recipients and fewer days alive and out of the hospital during the first 100 days after autologous and allogeneic HCT. Patients with pre‐transplant depression represent a population that is at risk for post‐transplant complications. Cancer 2017;123:1828–1838. © 2017 American Cancer Society.
BARD1 nonsense variant c.1921C>T in a patient with recurrent breast cancer
Gass, Jennifer , Tatro, Madeline, Blackburn, Patrick R. , Hines, Stephanie L., Atwal, Paldeep S. , Blackburn, Patrick , Hines, Stephanie, Atwal, Paldeep S

Mayo Clinic

Clinical Case Reports | January 4, 2017 | Volume: 5 | Issue: 2 | Pages: 104-107

10.1002/ccr3.793 | PMID 28174632 Get It

Key Clinical Message One of the strongest risk factors predisposing patients to breast cancer is a positive family history. In our study, we describe a patient diagnosed with multiple breast cancer tumors. Genetic analysis revealed a pathogenic variant in BARD1 , which is associated with an increased risk of developing certain types of cancer.
Salpingo-oophorectomy at the Time of Benign Hysterectomy: A Systematic Review
Rocca, Walter A. , Stewart, Elizabeth A. , Miller, Virginia M. , Faubion, Stephanie S. , Stewart, E A

Mayo Clinic

Obstetrics & Gynecology | December 24, 2016 | Volume: 129 | Issue: 1 | Pages: 202-203

10.1097/aog.0000000000001828 | PMID 28002288 Get It

Genetic variation at 16q24.2 is associated with small vessel stroke
Traylor, Matthew , Nalls, Mike A., Cotlarciuc, Ioana, Radmanesh, Farid , Hanscombe, Ken B. , Langefeld, Carl D. , Saleheen, Danish , Rost, Natalia S. , Yet, İdil , Spector, Tim D. , Bell, Jordana T. , Hannon, Eilís , Mill, Jonathan , Chauhan, Ganesh , Debette, Stéphanie , Bis, Joshua C. , Longstreth, W.T. , Seshadri, Sudha , Hamilton‐Bruce, Monica Anne , Jiménez-Conde, Jordi , Schmidt, Reinhold, Słowik, Agnieszka , Lemmens, Robin , Lindgren, Arne, Melander, Olle , Grewal, Raji P., Sacco, Ralph L., Rexrode, Kathryn M. , Arnett, Donna K. , Johnson, Julie A. , Benavente, Oscar, Wasssertheil‐Smoller, Sylvia, Lee, Jin‐Moo , Pulit, Sara L. , Wong, Quenna , Rich, Stephen S. , Bakker, Paul I. W. de , McArdle, Patrick F. , Woo, Daniel , Anderson, Christopher D. , Xu, Huichun , Heitsch, Laura , Fornage, Myriam , Stefansson, Kari, Þorsteinsdóttir, Unnur , Grétarsdóttir, Sólveig , Lewis, Cathryn M. , Sudlow, Cathie , Rothwell, Peter M. , Boncoraglio, Giorgio B. , Thijs, Vincent , Levi, Christopher , Kittner, Steven J. , Dichgans, Martin , Worrall, Bradford B. , Markus, Hugh S. , Malik, Rainer , Þorleifsson, Guðmar , Ikram, M. Arfan , Launer, Lenore J. , Cole, John W. , Lindgren, Arne, Rundek, Tatjana , Jern, Christina , Stefansson, Kari, Lewis, Cathryn M , Sharma, Pankaj Kumar , Meschia, James F. , Rosand, Jonathan M. , Mitchell, Braxton D. , Dichgans, Martin , Rich, Stephen S , Seshadri, Sudha , Debette, Stephanie , Lemmens, Robin , Arnett, Donna K , Lee, Jin-Moo

Mayo Clinic

Annals of Neurology | December 20, 2016 | Volume: 81 | Issue: 3 | Pages: 383-394

10.1002/ana.24840 | PMID 27997041 Get It

Objective Genome‐wide association studies (GWAS) have been successful at identifying associations with stroke and stroke subtypes, but have not yet identified any associations solely with small vessel stroke (SVS). SVS comprises one quarter of all ischemic stroke and is a major manifestation of cerebral small vessel disease, the primary cause of vascular cognitive impairment. Studies across neurological traits have shown that younger‐onset cases have an increased genetic burden. We leveraged this increased genetic burden by performing an age‐at‐onset informed GWAS meta‐analysis, including a large younger‐onset SVS population, to identify novel associations with stroke. Methods We used a three‐stage age‐at‐onset informed GWAS to identify novel genetic variants associated with stroke. On identifying a novel locus associated with SVS, we assessed its influence on other small vessel disease phenotypes, as well as on messenger RNA (mRNA) expression of nearby genes, and on DNA methylation of nearby CpG sites in whole blood and in the fetal brain. Results We identified an association with SVS in 4,203 cases and 50,728 controls on chromosome 16q24.2 (odds ratio [OR; 95% confidence interval {CI}] = 1.16 [1.10–1.22]; p = 3.2 × 10 −9 ). The lead single‐nucleotide polymorphism (rs12445022) was also associated with cerebral white matter hyperintensities (OR [95% CI] = 1.10 [1.05–1.16]; p = 5.3 × 10 −5 ; N = 3,670), but not intracerebral hemorrhage (OR [95% CI] = 0.97 [0.84–1.12]; p = 0.71; 1,545 cases, 1,481 controls). rs12445022 is associated with mRNA expression of ZCCHC14 in arterial tissues ( p = 9.4 × 10 −7 ) and DNA methylation at probe cg16596957 in whole blood ( p = 5.3 × 10 −6 ). Interpretation 16q24.2 is associated with SVS. Associations of the locus with expression of ZCCHC14 and DNA methylation suggest the locus acts through changes to regulatory elements. Ann Neurol 2017;81:383–394
Single‐center outcomes of combined heart and liver transplantation in the failing Fontan
D’Souza, Benjamin , Fuller, Stephanie , Gleason, Lacey P. , Hornsby, Nicole, Wald, Joyce , Krok, Karen , Shaked, Abraham , Goldberg, Lee R. , Pochettino, Alberto , Olthoff, Kim M. , Kim, Yuli Y.

Mayo Clinic

Clinical Transplantation | December 18, 2016 | Volume: 31 | Issue: 3 | Pages: No page available

10.1111/ctr.12892 | PMID 27988989 Get It

AbstractLong‐term outcomes of the Fontan operation include Fontan failure and liver disease. Combined heart‐liver transplantation (CHLT) is an option for select patients although limited data exist on this strategy. A retrospective review of Fontan patients 18 years or older referred for cardiac transplant evaluation between 2000 and 2013 at the Hospital of the University of Pennsylvania was performed. All patients were considered for potential CHLT. Clinical variables such as demographics, perioperative factors, and short‐term outcomes were reviewed. Of 17 referrals for cardiac transplantation, seven Fontan patients underwent CHLT. All patients who underwent CHLT had either advanced fibrosis or cirrhosis on liver biopsy. There were no perioperative deaths. The most common postoperative morbidity was acute kidney injury. Short‐term complications include one episode of acute liver rejection but no cardiac rejection greater than 1R. CHLT is an acceptable therapeutic option for patients with failing Fontan physiology who exhibit concomitant advanced liver fibrosis. However, optimal patient selection is currently undefined, and long‐term outcomes are not known.
Wide variations in blood product transfusion practices among providers who care for patients with acute leukemia in the United States
Pine, Alexander B. , Sekeres, Mikkael A. , Zelterman, Daniel , Komrokji, Rami S. , Litzow, Mark R. , Luger, Selina M. , Stone, Richard M. , Garcia‐Manero, Guillermo , Lee, Alfred Ian , Barbarotta, Lisa, Kasberg, Stephanie, Gore, Steven D. , Zeidan, Amer M. , Lee, Eun‐Ju , Steensma, David P. , Prébet, Thomas , Dezern, Amy Elizabeth , Erba, Harry Paul , Podoltsev, Nikolai , Hendrickson, Jeanne E. , Komrokji, Rami S , Sekeres, Mikkael A , Zeidan, Amer M

Mayo Clinic

Transfusion | November 23, 2016 | Volume: 57 | Issue: 2 | Pages: 289-295

10.1111/trf.13934 | PMID 27878822 Get It

BACKGROUNDTransfusion of blood products is a key component of the supportive management in patients with acute leukemia (AL). However high‐quality trial evidence and clinical outcome data to support specific transfusion goals for blood products for patients with AL remain limited leading to diverse transfusion practices. The primary objective of this study was to determine the spectrum of transfusion patterns in a variety of care settings among providers who treat AL patients.STUDY DESIGN AND METHODSA 31‐question survey queried providers caring for AL patients about the existence of institutional guidelines for transfusion of blood products, transfusion triggers for hemoglobin (Hb), platelets (PLTs), and fibrinogen in various settings including inpatient and outpatient and before procedures.RESULTSWe analyzed 130 responses and identified divergent transfusion Hb goals in hospitalized and ambulatory patients, fibrinogen goals for cryoprecipitate transfusions, and variation in practice for use of certain PLTs and red blood cell products. The least variable transfusion patterns were reported for PLT goals in thrombocytopenia and in the setting of invasive procedures such as bone marrow biopsy and lumbar punctures.CONCLUSIONSThis survey confirmed wide variations in blood product transfusion practices across several clinical scenarios in patients with AL. The findings emphasized the need for large prospective randomized trials to develop standardized evidence‐based guidelines for blood product transfusions in patients with AL with the goal of limiting unnecessary transfusions without compromising outcomes.
Does fair play reduce concussions? A prospective, comparative analysis of competitive youth hockey tournaments
Smith, Aynsley M., Gaz, Daniel V., Jorgensen, Janelle, Eickhoff, Chad, Fenske, Brooke M, Aney, Katie, Hansen, Ashley, Nanos, Stephanie , Larson, Dirk, Jorgensen, Janelle K, Hansen, Ashley A, Nanos, Stephanie M, Larson, Dirk R. , Krause, David A. , Fenske, BM, Stuart, Michael J.

Mayo Clinic

BMJ Open Sport & Exercise Medicine | November 22, 2016 | Volume: 2 | Issue: 1 | Pages: e000074

10.1136/bmjsem-2015-000074 | PMID 27900157 Get It

Background/aim To determine if Boys Bantam and Peewee and Girls U14 sustain fewer concussions, head hits, ‘other injuries’ and penalties in hockey tournaments governed by intensified fair play (IFP) than non-intensified fair play (NIFP). Methods A prospective comparison of IFP, a behaviour modification programme that promotes sportsmanship, versus control (non-intensified, NIFP) effects on numbers of diagnosed concussions, head hits without diagnosed concussion (HHWDC), ‘other injuries’, number of penalties and fair play points (FPPs). 1514 players, ages 11–14 years, in 6 IFP (N=950) and 5 NIFP (N=564) tournaments were studied. Results Two diagnosed concussions, four HHWDC, and six ‘other injuries’ occurred in IFP tournaments compared to one concussion, eight HHWDC and five ‘other injuries’ in NIFP. There were significantly fewer HHWDC in IFP than NIFP (p=0.018). However, diagnosed concussions, ‘other injuries’, penalties and FPPs did not differ significantly between conditions. In IFP, a minority of teams forfeited the majority of FPPs. Most diagnosed concussions, HHWDC, and other injuries occurred to Bantam B players and usually in penalised teams that forfeited their FPPs. Conclusions In response to significant differences in HHWDC between IFP and NIFP tournaments, the following considerations are encouraged: mandatory implementation of fair play in regular season and tournaments, empowering tournament directors to not accept heavily penalised teams, and introducing ‘no body checking’ in Bantam.
Immunizations for adult women
Larkin, Lisa , Faubion, Stephanie S.

Mayo Clinic

Menopause | November 8, 2016 | Volume: 23 | Issue: 12 | Pages: 1345-1347

10.1097/gme.0000000000000781 | PMID 27824687 Get It

Abstract Immunizations protect individual persons and contribute to public health by reducing morbidity and mortality associated with common infectious diseases. In this Practice Pearl, we review guidelines for adult immunizations and recent and potential changes in vaccines.